Therefore, we suggest that scabertopin can downregulate the expression of MMP-9 by inhibiting the activation of the FAK/PI3K/Akt signaling axis and, ultimately, inhibit the invasiveness of bladder cancer cells. Here, AKT1 is linked to urinary bladder carcinoma.